Cancer Pathophysiology and Cachexia Flashcards
regional lymph nodes
malignant cells will escape from tumours and get released in blood, where lymph nodes start getting activated, inflamed and enlarged ( trying to limit the progression of cancer spread) - gets classified according to the distance from primary tumor
Metastasis
invasion of distal tissues and organs - it has left the primary site (could be to the same organ but different spot - for example left lung to right lung is still metastasis)
for solid tutors how do we assess staging of cancer?
TNM
what is TNM
tumor-node- metastases
TNM - T?
from T1-T4 depending on the size of the tumor
TNM-N?
NO -N3 - depending on how many lymph nodes are affected
TNM-M?
has it metastasized?
M0 (no) or M1 (yes)
as soon as there is even one metastasis, what stage is it?
last stage (IV) - advanced cancer
chemotherapy agents will lead to what kind of side effects? why?
systemic side effects- bc it does not only target the cancer cells but other rapidly proliferating cells such as epithelial, hair follicles, taste buds
other common side effects of chemo
bone marrow suppression (anemia), N/V, anorexia, renal toxicity, cardiotoxicity, hepatoxicity, alopecia (spot baldness)
biological and targeted therapy side effects
generally less severe, for example estrogen receptor modulateers- hot flashes, but some may be more severe such as flu-like symptoms and organs damage
cachexia a disease or syndrome?
syndrome
def of cachexia
complex metabolic syndrome associated with an underlying illness characterized by weight loss ( of muscle with or without fat loss)
main difference between cachexia and starvation
trajectory of time of weight loss
chronic illness leads to ????
anorexia, inflammation, IR, hypogonadism and anemia which in turn leads to fat and muscle loss therefore leading to weight loss ad weakness and fatigue ( reduced muscle strength, VO2 was and PA)
consequences of muscle wasting
predicts poorer cancer associated outcomes - increase treatment toxicity (decreased lean mass can’t metabolize them as efficiently), decreased host response to tumor - less immune cells, decreases survivala and preformance status
% of patients with lung or gastro-intestinal tumour suffer from?? * watch for in case study
Sarcopenia-obesity - these outcomes are worse than obese or sarcopenia patients - they are less responsive to treatment
prevalence of cancer cachexia
50-80%
differentiate undernutrition, malnutrition, starvation and sarcopenia
insufficient food intake - undernutrion, insufficient or improper intake or one or more nutrients- malnutrition, starvation- total food deprivation, sarcopenia- decreased muscle mass
2 main components of cachexia
metabolic changes and reduced food intake
metabolic changes in cacheixa
hyper catabolism ( increased protein degradation) and hypo anabolism ( less responsive to anabolic stimuli)
what are metabolic changes driven by?
systemic inflammation and catabolic factor secreted by the tumour or host
differentiate primary and secondary anorexia
primary - physiological changes due to illness , secondary - from treatment
how do we measure hyper-catabolism or hypo anabolism to diagnose cancer cachexia??
weight loss, acute phase protein response, anorexia, appetite, satiety, hyper metabolism, inflammation